Evaluation of the Phased Radio Frequency Ablation System (VICTORY-AF)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01693120
(The study was stopped solely based on lower than expected enrollment rate.)
VICTORY AF is an IDE, prospective global, multi-center, single arm, controlled, unblinded, investigational clinical study. The purpose of this clinical study is to evaluate the risk of procedure and/or device related strokes in subjects with persistent or long-standing persistent atrial fibrillation (AF) undergoing ablation with the Phased RF System.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 75 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
History of symptomatic persistent or long-standing persistent atrial fibrillation
Failure of at least one anti-arrhythmic drug
Structural heart disease
Prior ablation in left atrium for AF
Known sensitivities (or allergy) to heparin, warfarin, contrast media
Contraindicated for MRI
Invasive cardiovascular procedure performed or planned within 3 month period of ablation procedure